Skip to main content

Peer Review reports

From: What is the future of targeted therapy in rheumatology: biologics or small molecules?

Original Submission
14 Nov 2013 Submitted Original manuscript
27 Nov 2013 Reviewed Reviewer Report - Steffen Gay
22 Jan 2014 Reviewed Reviewer Report - rieke alten
19 Feb 2014 Author responded Author comments - Alessandro Recchioni
Resubmission - Version 2
19 Feb 2014 Submitted Manuscript version 2
Publishing
19 Feb 2014 Editorially accepted
13 Mar 2014 Article published 10.1186/1741-7015-12-43

You can find further information about peer review here.

Back to article page